Peptide-metal chelate conjugates

Details Peptide-metal chelate conjugates Peptide-metal chelate conjugates

1994-05-12

1998-07-21

Kight, John

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

530300, 530311, 424 165, 534 10, 534 14, A61K 5100, A61M 3614

Patent

active

057831700

ABSTRACT:
This invention relates to diagnostic and radiodiagnostic agents, including radiolabeled scintigraphic imaging agents, and therapeutic and radiotherapeutic agents. The invention provides such agents and reagents for preparing such agents, and methods for producing and using such reagents. Specifically, the invention provides radiolabeled imaging agents and non-radioactively labeled imaging agents for imaging sites in a mammalian body and reagents for preparing these imaging agents. The invention also provides radiolabeled therapeutic agents, as well as non-radioactively labeled therapeutic agents, and reagents and methods for preparing these agents. The agents and reagents provided comprise a specific binding peptide, covalently linked to a metal ion-complexing moiety. Reagents, methods and kits for making such reagents, methods for labeling such reagents, and methods for using such labeled reagents are provided.

REFERENCES:
patent: 4235886 (1980-11-01), Friedinger
patent: 4434151 (1984-02-01), Byrne et al.
patent: 4444690 (1984-04-01), Fritzberg
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4485101 (1984-11-01), Coy et al.
patent: 4571430 (1986-02-01), Byrne et al.
patent: 4575556 (1986-03-01), Byrne et al.
patent: 4611054 (1986-09-01), Friedinger
patent: 4612366 (1986-09-01), Nutt
patent: 4668503 (1987-05-01), Hnatowich
patent: 4732684 (1988-03-01), Tolman
patent: 4832940 (1989-05-01), Eng et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 4861869 (1989-08-01), Nicolotti et al.
patent: 4871717 (1989-10-01), Coy et al.
patent: 4904642 (1990-02-01), Coy et al.
patent: 4925650 (1990-05-01), Nosco et al.
patent: 4943523 (1990-07-01), Stavrianopoulos
patent: 4965392 (1990-10-01), Fritzberg et al.
patent: 4986979 (1991-01-01), Morgan et al.
patent: 5061641 (1991-10-01), Shochat et al.
patent: 5091514 (1992-02-01), Fritzberg et al.
patent: 5095111 (1992-03-01), Lever et al.
patent: 5112953 (1992-05-01), Gustavson et al.
patent: 5175257 (1992-12-01), Kasina et al.
patent: 5180816 (1993-01-01), Dean et al.
patent: 5196515 (1993-03-01), Lever et al.
patent: 5225180 (1993-07-01), Dean et al.
patent: 5248764 (1993-09-01), Flanagan et al.
patent: 5382654 (1995-01-01), Lyle et al.
patent: 5405597 (1995-04-01), Dean et al.
patent: 5443815 (1995-08-01), Dean et al.
patent: 5508020 (1996-04-01), Dean et al.
patent: 5620675 (1997-04-01), McBride et al.
patent: 5632969 (1997-05-01), Flanagan et al.
Pearson et al (1996). J. Med Chem., vol. 39, No. 7, pp. 1361-1371 "Somatostatin Receptor-Binding Peptides Labeled with Technetium-99m: Chemistry and Initial Biological Studies".
Rhodes, 1974, "Considerations in the Radiolabeling of Albumin", Sem. Nucl. Med. 4: 281-293.
Davidson et al., 1981, "A New Class of Oxotechnetium(5+) Chelate Complexes containing a TcON.sub.2 S.sub.2 Core", Inorg. Chem. 20: 1629-1632.
Fritzberg et al., 1982, "Synthesis anbd Biological Evaluation of Tc-99m N,N'-Bis(mercaptoacetyl)-2,3-diaminopropanoate: A Potential Replacement
Byrne and Tolman, 1983, "Technetium-99m Bifunctional Chelating Agent--Thiolactone for Coupling to Biomolecules, N.sub.2 S.sub.2 Ligand for Chelation to Technetium", J. Nucl. Med. 24: P126.
Bryson et al., 1988, "Neutral Technetium(V) Complexes with Amide-Thiol-Thioether Chelating Ligands", Inorg. Chem. 27: 2154-2161.
Misra et al., 1989, "Synthesis of a Novel Diaminodithiol Ligand for Labeling Proteins and Small Molecules with Technetium-99m", Tet. Lett. 30: 1885-1888.
Bryson et al., 1990, "Protecting Groups inb the Preparation of Thiolate Complexes of Technetium", Inorg. Chem. 29: 2948-2951.
Knight et al., 1990, "Thrombus Imaging with Tc-99m Synthetic peptides Reactive with Activated Platelets", J. Nucl. Med. 31: 757 #209.
Bakker et al., 1990, "Receptor Scintigraphy with a Radioiodinated Somatostatin Analogue: Radiolabeling, Purification, Biologic Activity, and In Vivo Application in Animals", J. Nucl. Med. 31: 1501-1509.
Bakker et al., 1991, "In Vivo Use of a Radioiodinated Somatostatin Analogue: Dynamics, Metabolism, and Binding to Somatostatin Receptor-Positive Tumors in Man", J. Nucl. Med. 32: 1184-1189. Scintigraphy in Neuro-endocrine Tumors", J. Nucl. Med. 32: 981, Abstract #305.
Faglia et al., 1991, "In Vivo Detection of Somatostatin Receptors in Patients with Functionless Pituitary Adenomas by Means of a Radioiodinated Metab. 73: 850-856.
Albert et al., 1991, "A Somatostatin Ananlogue to Image (SDZ 215-811)", Abstract LM10, 12th American Peptide Symposium.
Cox et al., 1991, "Technetium Labeled Somatostatin: A Potential Agent for In Vivo Tumor Localization", Abstract, 7th International Symposium on Radiopharmacology, p. 16.
Schwartz et al., 1991, "Preparation of Hydrazino-Modified Proteins and Their Use for the Synthesis of .sup.99m Tc-Protein Conjugates", Bioconjugate Chem. 2: 333.
Krenning et al., 1992, "Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dositometry and Comparison with Iodine-123-Tyr-3-Octreotide", J. Nucl. Med. 33: 652-658.
Bomanji et al., 1992, "A Scintigraphic Comparison of Iodine-123-Metaiodobenzylguanidine and an Iodine-Labeled Somatostatin Analog (Tyr-3-Octreotide) in Metastatic Carcinoid Tumors", J. Nucl. Med. 33: 1121-1124.

Affiliated with

Also associated with

Rating

Peptide-metal chelate conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide-metal chelate conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide-metal chelate conjugates will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1644211